The role of short chain fatty acid substrates in aerobic and glycolytic metabolism in primary cultures of renal proximal tubule cells.
This study examined the role of odd and even short-chain fatty acid substrates on aerobic and glycolytic metabolism in well-aerated primary cultures of rabbit renal proximal tubule cells (RPTC). Increasing oxygen delivery to primary cultures of RPTC by shaking the dishes (SHAKE) reduced total lactate levels and lactate dehydrogenase (LDH) activity and reduced net glucose consumption compared to RPTC cultured under standard conditions (STILL). The addition of butyrate, valerate, heptanoate, or octanoate to SHAKE RPTC produced variable effects on glycolytic metabolism. Although butyrate and heptanoate further reduced total lactate levels and net glucose consumption during short-term culture (< 24 h), no fatty acid tested further reduced total lactate levels, net glucose consumption, or LDH activity during long-term culture (7 days). During the first 12 h of culture, maintenance of aerobic metabolism in SHAKE RPTC was dependent on medium supplementation with fatty acid substrates (2 mM). However, by 24 h, SHAKE RPTC did not require fatty acid substrates to maintain levels of aerobic metabolism equivalent to freshly isolated proximal tubules and greater than STILL RPTC. This suggests that SHAKE RPTC undergo adaptive changes between 12 and 24 h of culture, which give RPTC the ability to utilize other substrates for mitochondrial oxidation, therefore allowing greater expression of mitochondrial oxidative potential in SHAKE RPTC than in STILL RPTC.
Griner
R D
RD
Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens 30602.
Aleo
M D
MD
Schnellmann
R G
RG
D000332:Aerobiosis; D000818:Animals; D002087:Butyrates / Q000494:pharmacology; D020148:Butyric Acid; D002210:Caprylates / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D046508:Culture Techniques / Q000379:methods; D005230:Fatty Acids, Nonesterified / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D006019:Glycolysis / Q000187:drug effects; D006537:Heptanoates / Q000494:pharmacology; D007687:Kidney Tubules, Proximal / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D009761:Nystatin / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D010421:Pentanoic Acids / Q000494:pharmacology; D011817:Rabbits
D002087:Butyrates; D002210:Caprylates; D005230:Fatty Acids, Nonesterified; D006537:Heptanoates; D007773:Lactates; D010421:Pentanoic Acids; D020148:Butyric Acid; D009761:Nystatin; D007770:L-Lactate Dehydrogenase; C038780:n-pentanoic acid; C031492:octanoic acid